Showing 1,861 - 1,880 results of 14,649 for search '(( significantly ((greater decrease) OR (mean decrease)) ) OR ( significant increase decrease ))', query time: 0.28s Refine Results
  1. 1861
  2. 1862
  3. 1863
  4. 1864
  5. 1865
  6. 1866

    Summary of study eligibility criteria. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  7. 1867

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  8. 1868

    NPF-NPFR pathway in LNd-LPN feedback circuit fine-tune cooling induced locomotion increase. by Xin Yuan (174619)

    Published 2024
    “…(C, D) Optogenetic activation of LNds using CsChrimson (<i>DvPdf-Gal4>Uas-CsChrimson</i>, red line) decreases sleep and this decrease effect was enhanced by NPF RNAi (<i>DvPdf-Gal4>Uas-CsChrimson; Uas-NPF RNAi</i>; green line). …”
  9. 1869
  10. 1870
  11. 1871
  12. 1872
  13. 1873
  14. 1874
  15. 1875
  16. 1876
  17. 1877
  18. 1878
  19. 1879
  20. 1880